Beckman Coulter to Host Fourth Annual Investor Conference on March 24 and 26, 2003.Business Editors & Health/Medical Writers FULLERTON, Calif.--(BUSINESS WIRE)--Feb. 19, 2003 Beckman Coulter This article needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. , Inc. (NYSE NYSE See: New York Stock Exchange :BEC) announced today it will host its Fourth Annual Investor Conference in the form of two events. The first event is set for Monday, March 24, 2003 at the company's corporate headquarters in Fullerton, California Fullerton is a city located in northern Orange County, California, United States. As of the 2000 census, the city had a total population of 126,003. It was founded in 1887 by George and Edward Amerige and named for George H. ; the second on Wednesday, March 26, 2003 in New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of , New York. Attendees at the New York meeting will have the option of touring the Beckman Coulter Vision Center to view the company's products. The conference will be hosted by John P. Wareham, chairman, president and chief executive officer; and a host of top corporate, clinical diagnostics and biomedical research Biomedical research (or experimental medicine), in general simply known as medical research, is the basic research or applied research conducted to aid the body of knowledge in the field of medicine. executives, who will discuss the company's strategy and high potential areas. If you would like to attend one of these meetings, please contact Beckman Coulter's Investor Relations Investor relations The process by which the corporation communicates with its investors. department for event details at 714-773-7917 or send an e-mail to: cgskoglund@beckman.com. The conference scheduled for Monday, March 24, 2003 at 11:30 p.m. ET (8:30am PT) will be webcast live. The conference is accessible to all investors through Beckman Coulter's website at www.beckmancoulter.com or www.streetevents.com . When accessing the webcast through the Beckman Coulter site, select "more IR info" under Investor Relations and find the call listed under "What's New". The webcast will be archived for future on-demand replay through Monday, April 7, 2003. Beckman Coulter, Inc. is a global biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. company, headquartered in Fullerton, California. The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2.06 billion in 2002, with 62% of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion